Ryan Wallace

Ryan Wallace

Auto-generated profile, based on publicly available information

Ryan Wallace

Section of Interventional Cardiology MedStar Washington Hospital Center Washington District of Columbia USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2018 in Translational Research
Verified
Journal Article
Closed access
HHHongliang He
Hongliang He
QYQuan Yuan
Quan Yuan
JBJinghua Bie
Jinghua Bie
RWRyan L. Wallace
Ryan L. Wallace
PYPaul J. Yannie
Paul J. Yannie
SGShobha Ghosh
Shobha Ghosh

27 August 2021 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
PDF file
TATauseef Akhtar
Tauseef Akhtar
RWRyan Wallace
Ryan Wallace
UDUsama A. Daimee
Usama A. Daimee
EHErica Hart
Erica Hart
AAArmin Arbab‐Zadeh
Armin Arbab‐Zadeh
DSDavid Spragg
David Spragg

23 March 2024 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
IMIlan Merdler
Ilan Merdler
RWRyan Wallace
Ryan Wallace
ABAvantika Banerjee
Avantika Banerjee
GMGiorgio A. Medranda
Giorgio A. Medranda
PRPavan Reddy
Pavan Reddy
HHHayder D. Hashim
Hayder D. Hashim

25 November 2021 in Indian Pacing and Electrophysiology Journal
Verified
Journal Article
Open access
TATauseef Akhtar
Tauseef Akhtar
RWRyan Wallace
Ryan Wallace
UDUsama A. Daimee
Usama A. Daimee
BSBhradeev Sivasambu
Bhradeev Sivasambu
EHErica Hart
Erica Hart
DSDavid Spragg
David Spragg
There are limited data describing the experience of radiofrequency (RF) vs. cryoballoon (CB) ablation for atrial fibrillation (AF) among elderly patients in the United States. We conducted a retrospective analysis of patients ≥75 years of age undergoing index RF vs. CB ablation between January 2014 and May 2020 at our center. The choice of ablation technique was left to the operator's discretion. Major complications and efficacy, defined as freedom from any atrial tachyarrhythmia (ATA) lasting ≥30 s after one year of follow-up, were assessed in patients with index RF vs. CB ablation. In our cohort of 186 patients, the median age was 78 (76–81) years, 54.8% were men, and 39.2% had persistent AF. The median CHA2DS2-VASc score was 4 (3–4), while the median duration of AF was 3 (1–7) years. The majority (n = 112, 60.2%) underwent RF ablation. The median procedure time was significantly lower in CB group (197 vs 226.5 min, p=<0.01). The incidence of complications was similar in the two sub-groups (RF: 1.8% vs. CB: 2.7%, p = 0.67). Similarly, arrhythmia-free survival rate on antiarrhythmic drugs at 1-year follow-up remained statistically comparable (63.4% vs. 68.9%, p = 0.33) between patients receiving RF vs. CB ablation. The safety and efficacy of RF vs. CB ablation for AF remained comparable in our cohort of patients older than 75 years. CB ablation was associated with a shorter procedure time.

11 December 2024 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
KCKalyan R. Chitturi
Kalyan R. Chitturi
RWRyan Wallace
Ryan Wallace
MLMarta Lorente‐Ros
Marta Lorente‐Ros
IMIlan Merdler
Ilan Merdler
ACAbhishek Chaturvedi
Abhishek Chaturvedi
RWRon Waksman
Ron Waksman

11 September 2025 in JACC: Case Reports
Verified
Journal Article
Open access
RRRimsha Rana
Rimsha Rana
RWRyan L. Wallace
Ryan L. Wallace
RWRon Waksman
Ron Waksman
HHHayder D. Hashim
Hayder D. Hashim
BCBrian C. Case
Brian C. Case
The 5-fluorouracil (5-FU) component of 5-fluorouracil, leucovorin, and oxaliplatin (FOLFOX) chemotherapy is a known cause of coronary vasospasm. Diagnosis can be difficult, often leading to interruption of chemotherapy. A 53-year-old man with a history of colorectal cancer developed new-onset angina after initiation of FOLFOX chemotherapy. He underwent a left heart catheterization, coronary functional testing (CFT), and acetylcholine (ACh) provocation. ACh provocation elicited similar angina, consistent with microvascular vasospasm. This prompted initiation of calcium-channel blockers and adjustments to chemotherapy administration, preventing further angina. CFT with ACh provocation should be considered in patients undergoing chemotherapy with 5-FU. As 5-FU coronary vasospasm is often transient, ACh provocation can identify patients who would benefit from calcium-channel blockers and changing 5-FU administration from continuous to bolus dosing. This case highlights the utility of CFT in identifying and guiding treatment in suspected cases of 5-FU-associated coronary vasospasm.